These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 37214253)

  • 1. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.
    Zhao J; Guo S; Schrodi SJ; He D
    Front Immunol; 2022; 13():930278. PubMed ID: 35990673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis: p53-regulated metabolic cell death?
    Xiong C; Ling H; Hao Q; Zhou X
    Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
    Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
    Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
    Ozkan E; Bakar-Ates F
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of cuproptosis and its relevance to distinct diseases.
    Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
    Apoptosis; 2024 Aug; 29(7-8):981-1006. PubMed ID: 38824478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis and physical training: A review.
    Kordi N; Saydi A; Azimi M; Mazdarani F; Gadruni K; Jung F; Karami S
    Clin Hemorheol Microcirc; 2024 Jul; ():. PubMed ID: 39031346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis: potential new direction in diabetes research and treatment.
    Qu J; Wang Y; Wang Q
    Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
    Whitfield JF; Morley P; Willick GE
    Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of cuproptosis in Parkinson's disease.
    Huang M; Zhang Y; Liu X
    Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress in cuproptosis in liver cancer.
    Chen L; Liu D; Tan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future developments in osteoporosis therapy.
    Ng KW
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):371-84. PubMed ID: 19857200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.
    Ning S; Lyu M; Zhu D; Lam JWY; Huang Q; Zhang T; Tang BZ
    ACS Nano; 2023 Jun; 17(11):10206-10217. PubMed ID: 37183977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.